Exhibitors & Sponsors
Advanced Accelerator Applications, a Novartis company, is an innovative radiopharmaceutical company developing, producing and commercializing molecular nuclear medicine theragnostics. AAA’s theragnostic platform is based on radiolabeling a targeting molecule with either gallium Ga 68 for diagnostic use, or lutetium Lu 177 for therapy. AAA’s first theragnostic pairing for neuroendocrine tumors includes diagnostic drugs NETSPOT® and SomaKit TOC®; and therapeutic Lutathera®. Additional theragnostics in development target gastrointestinal stromal tumors (GIST), and prostate and breast cancer.
Advanced Care Scripts (ACS)
Advanced Care Scripts provides specialty pharmacy management services for patients on biotech therapies. The company engages in the management and dispensing of specialty medications and oral oncology products, as well as provides Medicare reimbursement support services.
Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics. A biotechnology pioneer since 1980, Amgen has reached millions of patients around the world and is developing a pipeline of medicines with breakaway potential.
Bayer is a global enterprise with core competencies in the life science fields of healthcare and agriculture. Its products and services are designed to benefit people and improve their quality of life. At the same time, the group aims to create value through innovation, growth, and high earning power.
Bird & Cronin, Inc. manufactures specialty surgical care products and orthopedic soft goods. We are highlighting our patented post-surgical drainage bulb securement products designed by a nurse. Our products help decrease complications, reduce infections and improve patient outcomes by individually securing JP drains independent of clothing with no safety pins.
Boehringer Ingelheim is committed to discovering and developing cancer treatments for the benefit of patients. Our scientific discoveries and research are applied to develop a wide range of therapies in both solid tumors and hematologic cancers. Development programs include angiogenesis inhibition, signal transduction inhibition, and cell-cycle kinase inhibition, among others.
BriovaRx is a leading specialty pharmacy services company dedicated to helping administer and deliver high-quality, cost-effective specialty pharmacy care. BriovaRx combines technology, data and expertise to provide educational resources, 24/7 pharmacy support and trusted advice to the individuals, caregivers and care teams we serve.
Bristol-Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. For more information about Bristol-Myers Squibb, visit us at BMS.com or follow us on LinkedIn, Twitter, YouTube and Facebook.
Cancer Legal Resource Center (CLRC) a 501C-3 non-profit, public interest advocacy organization that champions the civil rights of people with disabilities as well as those affected by cancer and other serious illness. CLRC provides free legal information and through its national telephone assistance line, outreach programs and community activities to educate and to support cancer patients, their families, healthcare professionals and advocates on matters like maintaining employment through treatment, accessing healthcare and government benefits, taking medical leave and estate planning.
Celgene Corporation (Nasdaq:CELG) is a global biopharmaceutical company that is helping healthcare providers turn incurable cancers into chronic, manageable diseases through innovative therapies. This dedication to medical progress goes hand-in-hand with our industry-leading patient support and access programs. Together, these aspects form the core of our commitment to patients worldwide.
Exelixis, Inc. is a commercially successful, oncology-focused biotechnology company that strives to accelerate the discovery, development, and commercialization of new medicines for difficult-to-treat cancers. With targeted business development and internal drug discovery, we aim to deliver the next generation of Exelixis medicines and help patients recover stronger and live longer.
Two sisters founded heart&core, designing Ultimate Support Sports Bras for women like their mother, who had treatments/surgery for breast cancer. From there, they launched a post-surgical line. Their patented Bonita and Larissa Bras, developed with feedback from patients, nurses, and doctors, enhance healing following breast, heart, or lung surgeries.
At Janssen Oncology, we’re shaping the future of cancer treatment. Our purpose is driven by an urgency and commitment to bringing transformational cancer solutions to the people who need them. With our partners, we focus on delivering solutions that make a positive impact on human health.
For more than 50 years, Lilly has been dedicated to delivering life-changing medicines and support to people living with cancer and those who care for them. Lilly is determined to build on this heritage and continue making life better for all those affected by cancer around the world.
At Novartis, our mission is to discover new ways to improve and extend people’s lives. We use science-based innovation to address some of society’s most challenging health care issues. We discover and develop breakthrough treatments and find new ways to deliver them to as many people as possible.
Onco360 is one of the country’s largest independent providers of oncology specialty pharmacy services. Dedicated to cancer care, Onco360 provides pharmacy solutions to oncologists, payers, hospitals, and health systems through its URAC-, ACHC-, and JCAHO-accredited oncology pharmacies. These services include robust dispensing, clinical management, financial assistance, and administrative support.
PatientPoint® powers more effective patient-physician engagements across all points of care. For 30 years, healthcare providers have trusted PatientPoint to help deliver the right message at the right time to drive positive results. Offering the most comprehensive solution set to engage patients and medical staff, PatientPoint print, digital and mobile technologies enrich the entire care experience.
Pfizer Oncology is committed to pursuing innovative treatments that are helping to redefine life with cancer. As an oncology leader with one of the most robust oncology pipelines in the industry, we are focused on translating scientific breakthroughs into clinical application. Additionally, we are dedicated to working collaboratively with the community to make a positive impact on people’s lives. Learn more about Pfizer Oncology.
Puma Biotechnology, Inc. is a biopharmaceutical company with a focus on the development and commercialization of innovative products to enhance cancer care. Puma is dedicated to advancing the treatment of HER2+ breast cancer and supporting women, their families, and the breast cancer community.
Roche is a global pioneer in pharmaceuticals and diagnostics focused on advancing science to improve people’s lives. The combined strengths of pharmaceuticals and diagnostics under one roof have made Roche the leader in personalized healthcare—a strategy that aims to fit the right treatment to each patient in the best way possible.
RxVantage is a free tool used by thousands of medical practices. It simplifies finding reps by name, product, or company and allows reps to schedule appointments directly in custom online calendars, saving hours of administrative time that could be devoted to clinical care. RxAssist aggregates patient assistance programs, providing patients with vouchers and grants for products and services.
Sanofi Genzyme, the specialty care business unit of Sanofi, focuses on rare diseases, multiple sclerosis, oncology, and immunology. We help people with debilitating and complex conditions that are often difficult to diagnose and treat. Our approach is shaped by our experience developing highly specialized treatments and forging close relationships with physician and patient communities. We are dedicated to discovering and advancing new therapies, providing hope to patients and their families around the world.
Sarah Cannon, the Cancer Institute of HCA Healthcare, offers integrated cancer treatments with convenient access to cutting-edge therapies for those facing cancer in communities across the United States and United Kingdom. Through its services, Sarah Cannon is providing state-of-the-art cancer care close to home for hundreds of thousands of patients, a number unmatched by any single cancer center.
Sirtex Medical develops and delivers oncology treatments using novel small particle technology to improve outcomes for patients with cancer. SIR-Spheres® Y-90 resin microspheres target liver tumors with radiation via the hepatic artery during Selective Internal Radiation Therapy (SIRT). Recent SIRFLOX Study data showed a 7.9 month improvement in Progression-Free Survival in the liver for patients with unresectable mCRC treated first line with SIR-Spheres Y-90 resin microspheres plus standard chemotherapy.
TerSera Therapeutics is a specialty pharmaceutical company headquartered in suburban Chicago with a focus on select therapeutic areas, including oncology. Our mission is to develop products which truly make a difference for patients. Our focus is to bring intelligent solutions to our customers that go beyond the therapy itself in order to provide improved patient outcomes. We look forward to meeting you!
Teva Oncology is a top US oncology company that strives to improve the lives of people affected by cancer. Our focus is to provide solutions in hematologic malignancies, solid tumors and supportive care. Teva Oncology's vision is to change the course of cancer care one patient at a time.
Tolmar Pharmaceuticals, Inc. is committed to the development, approval, and commercialization of specialty pharmaceutical products dedicated to advancing patient care in urology. We are focused on the needs of today, with a vision of tomorrow that drives our dedication to the urology community and the patients it serves.
Water-Jel Technologies, the company that developed and manufactures R1 and R2, is a world leader and expert in the treatment of burns. R1 and R2 are solutions to the problem of treating the side effects experienced by skin during and after radiotherapy treatment (radiation dermatitis) The innovative new cooling treatment cools the damaged area in two stages through cooling, relieving pain, hydrating the skin in the short- and long-term. It incorporates LACTOKINE, a milk protein in its formulation, which helps to strengthen the cell’s ability to withstand stress.